March 31, 2010 - Partnership to Contribute to Improved Quality of Diabetes Care - Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) and AgaMatrix Inc. announced that they have signed an agreement for the development, supply and commercialization of blood glucose monitoring (BGM) solutions.Under the terms of the agreement, AgaMatrix and sanofi-aventis will co-develop innovative solutions in diabetes care with the aim to simplify patients’ and healthcare providers’ diabetes management experience. These BGM solutions will be exclusive to sanofi-aventis and are designed to be synergistic to sanofi-aventis’ diabetes portfolio.
“AgaMatrix provides us with an excellent opportunity to develop a comprehensive offer combining our leading insulins LANTUS® and APIDRA® with easy-to-use and reliable blood glucose monitors,”... [PDF]Sanofi-aventis' Press Release -
